Request for Covid-19 Impact Assessment of this Report
The United States Bacille Calmette-Guerin Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Bacille Calmette-Guerin Vaccine market, reaching US$ million by the year 2028. As for the Europe Bacille Calmette-Guerin Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Bacille Calmette-Guerin Vaccine players cover Merck, Sanofi Pasteur, Japan BCG Lab, and China National Biotec, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacille Calmette-Guerin Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Immune
Therapy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Private Distribution Channel
Public Distribution Channel
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bacille Calmette-Guerin Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bacille Calmette-Guerin Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bacille Calmette-Guerin Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Bacille Calmette-Guerin Vaccine Segment by Type
2.2.1 Immune
2.2.2 Therapy
2.3 Bacille Calmette-Guerin Vaccine Sales by Type
2.3.1 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Bacille Calmette-Guerin Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bacille Calmette-Guerin Vaccine Sale Price by Type (2017-2022)
2.4 Bacille Calmette-Guerin Vaccine Segment by Application
2.4.1 Private Distribution Channel
2.4.2 Public Distribution Channel
2.5 Bacille Calmette-Guerin Vaccine Sales by Application
2.5.1 Global Bacille Calmette-Guerin Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Bacille Calmette-Guerin Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bacille Calmette-Guerin Vaccine Sale Price by Application (2017-2022)
3 Global Bacille Calmette-Guerin Vaccine by Company
3.1 Global Bacille Calmette-Guerin Vaccine Breakdown Data by Company
3.1.1 Global Bacille Calmette-Guerin Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Bacille Calmette-Guerin Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Company (2020-2022)
3.2.2 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Bacille Calmette-Guerin Vaccine Sale Price by Company
3.4 Key Manufacturers Bacille Calmette-Guerin Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bacille Calmette-Guerin Vaccine Product Location Distribution
3.4.2 Players Bacille Calmette-Guerin Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bacille Calmette-Guerin Vaccine by Geographic Region
4.1 World Historic Bacille Calmette-Guerin Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Bacille Calmette-Guerin Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bacille Calmette-Guerin Vaccine Annual Revenue by Geographic Region
4.2 World Historic Bacille Calmette-Guerin Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Bacille Calmette-Guerin Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bacille Calmette-Guerin Vaccine Annual Revenue by Country/Region
4.3 Americas Bacille Calmette-Guerin Vaccine Sales Growth
4.4 APAC Bacille Calmette-Guerin Vaccine Sales Growth
4.5 Europe Bacille Calmette-Guerin Vaccine Sales Growth
4.6 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Growth
5 Americas
5.1 Americas Bacille Calmette-Guerin Vaccine Sales by Country
5.1.1 Americas Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022)
5.1.2 Americas Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022)
5.2 Americas Bacille Calmette-Guerin Vaccine Sales by Type
5.3 Americas Bacille Calmette-Guerin Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacille Calmette-Guerin Vaccine Sales by Region
6.1.1 APAC Bacille Calmette-Guerin Vaccine Sales by Region (2017-2022)
6.1.2 APAC Bacille Calmette-Guerin Vaccine Revenue by Region (2017-2022)
6.2 APAC Bacille Calmette-Guerin Vaccine Sales by Type
6.3 APAC Bacille Calmette-Guerin Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bacille Calmette-Guerin Vaccine by Country
7.1.1 Europe Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022)
7.1.2 Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022)
7.2 Europe Bacille Calmette-Guerin Vaccine Sales by Type
7.3 Europe Bacille Calmette-Guerin Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bacille Calmette-Guerin Vaccine by Country
8.1.1 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Type
8.3 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bacille Calmette-Guerin Vaccine
10.3 Manufacturing Process Analysis of Bacille Calmette-Guerin Vaccine
10.4 Industry Chain Structure of Bacille Calmette-Guerin Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bacille Calmette-Guerin Vaccine Distributors
11.3 Bacille Calmette-Guerin Vaccine Customer
12 World Forecast Review for Bacille Calmette-Guerin Vaccine by Geographic Region
12.1 Global Bacille Calmette-Guerin Vaccine Market Size Forecast by Region
12.1.1 Global Bacille Calmette-Guerin Vaccine Forecast by Region (2023-2028)
12.1.2 Global Bacille Calmette-Guerin Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bacille Calmette-Guerin Vaccine Forecast by Type
12.7 Global Bacille Calmette-Guerin Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Bacille Calmette-Guerin Vaccine Product Offered
13.1.3 Merck Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Product Offered
13.2.3 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Lab
13.3.1 Japan BCG Lab Company Information
13.3.2 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Offered
13.3.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Japan BCG Lab Main Business Overview
13.3.5 Japan BCG Lab Latest Developments
13.4 China National Biotec
13.4.1 China National Biotec Company Information
13.4.2 China National Biotec Bacille Calmette-Guerin Vaccine Product Offered
13.4.3 China National Biotec Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 China National Biotec Main Business Overview
13.4.5 China National Biotec Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India Bacille Calmette-Guerin Vaccine Product Offered
13.5.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Intervax
13.6.1 Intervax Company Information
13.6.2 Intervax Bacille Calmette-Guerin Vaccine Product Offered
13.6.3 Intervax Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Intervax Main Business Overview
13.6.5 Intervax Latest Developments
13.7 GSBPL
13.7.1 GSBPL Company Information
13.7.2 GSBPL Bacille Calmette-Guerin Vaccine Product Offered
13.7.3 GSBPL Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GSBPL Main Business Overview
13.7.5 GSBPL Latest Developments
14 Research Findings and Conclusion
Table 1. Bacille Calmette-Guerin Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bacille Calmette-Guerin Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Immune
Table 4. Major Players of Therapy
Table 5. Global Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)
Table 6. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Bacille Calmette-Guerin Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Bacille Calmette-Guerin Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)
Table 11. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Bacille Calmette-Guerin Vaccine Revenue by Application (2017-2022)
Table 13. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Bacille Calmette-Guerin Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Bacille Calmette-Guerin Vaccine Sales by Company (2020-2022) & (Units)
Table 16. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Bacille Calmette-Guerin Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Bacille Calmette-Guerin Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Bacille Calmette-Guerin Vaccine Producing Area Distribution and Sales Area
Table 21. Players Bacille Calmette-Guerin Vaccine Products Offered
Table 22. Bacille Calmette-Guerin Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bacille Calmette-Guerin Vaccine Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Bacille Calmette-Guerin Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Bacille Calmette-Guerin Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Bacille Calmette-Guerin Vaccine Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Bacille Calmette-Guerin Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022) & (Units)
Table 34. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)
Table 38. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)
Table 40. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Bacille Calmette-Guerin Vaccine Sales by Region (2017-2022) & (Units)
Table 42. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Bacille Calmette-Guerin Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)
Table 46. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)
Table 48. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022) & (Units)
Table 50. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)
Table 54. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)
Table 56. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Bacille Calmette-Guerin Vaccine
Table 66. Key Market Challenges & Risks of Bacille Calmette-Guerin Vaccine
Table 67. Key Industry Trends of Bacille Calmette-Guerin Vaccine
Table 68. Bacille Calmette-Guerin Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Bacille Calmette-Guerin Vaccine Distributors List
Table 71. Bacille Calmette-Guerin Vaccine Customer List
Table 72. Global Bacille Calmette-Guerin Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Bacille Calmette-Guerin Vaccine Sales Market Forecast by Region
Table 74. Global Bacille Calmette-Guerin Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Bacille Calmette-Guerin Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Bacille Calmette-Guerin Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Bacille Calmette-Guerin Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Bacille Calmette-Guerin Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Bacille Calmette-Guerin Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Bacille Calmette-Guerin Vaccine Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Bacille Calmette-Guerin Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Bacille Calmette-Guerin Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Bacille Calmette-Guerin Vaccine Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Bacille Calmette-Guerin Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Bacille Calmette-Guerin Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Bacille Calmette-Guerin Vaccine Product Offered
Table 94. Merck Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Sanofi Pasteur Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pasteur Bacille Calmette-Guerin Vaccine Product Offered
Table 99. Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sanofi Pasteur Main Business
Table 101. Sanofi Pasteur Latest Developments
Table 102. Japan BCG Lab Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Offered
Table 104. Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Japan BCG Lab Main Business
Table 106. Japan BCG Lab Latest Developments
Table 107. China National Biotec Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. China National Biotec Bacille Calmette-Guerin Vaccine Product Offered
Table 109. China National Biotec Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. China National Biotec Main Business
Table 111. China National Biotec Latest Developments
Table 112. Serum Institute of India Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Serum Institute of India Bacille Calmette-Guerin Vaccine Product Offered
Table 114. Serum Institute of India Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Serum Institute of India Main Business
Table 116. Serum Institute of India Latest Developments
Table 117. Intervax Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Intervax Bacille Calmette-Guerin Vaccine Product Offered
Table 119. Intervax Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Intervax Main Business
Table 121. Intervax Latest Developments
Table 122. GSBPL Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. GSBPL Bacille Calmette-Guerin Vaccine Product Offered
Table 124. GSBPL Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. GSBPL Main Business
Table 126. GSBPL Latest Developments
List of Figures
Figure 1. Picture of Bacille Calmette-Guerin Vaccine
Figure 2. Bacille Calmette-Guerin Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bacille Calmette-Guerin Vaccine Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Bacille Calmette-Guerin Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bacille Calmette-Guerin Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Immune
Figure 10. Product Picture of Therapy
Figure 11. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type in 2021
Figure 12. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Bacille Calmette-Guerin Vaccine Consumed in Private Distribution Channel
Figure 14. Global Bacille Calmette-Guerin Vaccine Market: Private Distribution Channel (2017-2022) & (Units)
Figure 15. Bacille Calmette-Guerin Vaccine Consumed in Public Distribution Channel
Figure 16. Global Bacille Calmette-Guerin Vaccine Market: Public Distribution Channel (2017-2022) & (Units)
Figure 17. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application in 2021
Figure 19. Bacille Calmette-Guerin Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Bacille Calmette-Guerin Vaccine Sales 2017-2022 (Units)
Figure 26. Americas Bacille Calmette-Guerin Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Bacille Calmette-Guerin Vaccine Sales 2017-2022 (Units)
Figure 28. APAC Bacille Calmette-Guerin Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Bacille Calmette-Guerin Vaccine Sales 2017-2022 (Units)
Figure 30. Europe Bacille Calmette-Guerin Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales 2017-2022 (Units)
Figure 32. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Bacille Calmette-Guerin Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Bacille Calmette-Guerin Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Bacille Calmette-Guerin Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Bacille Calmette-Guerin Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Bacille Calmette-Guerin Vaccine
Figure 63. Industry Chain Structure of Bacille Calmette-Guerin Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...